Novi Zan (688105.SH) announced that Nanjing Novi Zan Medical Technology Co., Ltd., a wholly-owned subsidiary of the company (“Novi...
Zhitong Finance App News, Novi Zan (688105.SH) announced that Nanjing Novi Zan Medical Technology Co., Ltd. (“Novi Zan Medical”), a wholly-owned subsidiary of the company, recently signed a “Cooperation Agreement” with Shangyao Kangdelle (Shanghai) Pharmaceutical Co., Ltd. (“Shanghai Kangdler”) on business cooperation matters such as the company's Alzheimer's disease (AD blood test products).
According to the announcement, Shanghai Pharmaceutical Kangdele is an enterprise directly under Shanghai Pharmaceutical Holdings Co., Ltd. (“Shanghai Pharmaceutical Holdings”) under Shanghai Pharmaceutical Group Co., Ltd. (601607.SH, 02607.HK).